ArticleTechnology in cancer research & treatment

CCT3 Facilitates the Malignant Progression of NSCLC and SCLC via PI3 K/AKT-EMT Axis and Emerges as a Novel Serum Diagnostic Biomarker.

Guobin Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.